PA
GENI icon

PharVision Advisers’s Genius Sports GENI Stock Holding History

PharVision Advisers’s Portfolio GENI Stock Details GENI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,672
Closed -$78.3K – 86
2026
Q1 		$78.3K Buy
+17,672
New +$126K 0.79% 67
2025
Q2 		– Sell
-11,765
Closed -$118K – 335
2025
Q1 		$118K Buy
+11,765
New +$109K 0.16% 240

Other funds holding GENI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

PharVision Advisers's GENI Position: Q2 2026 in Review

PharVision Advisers sold out of Genius Sports (GENI) in Q2 2026, closing a stake of 17,672 shares — an estimated $78.3K sold.

PharVision Advisers first reported a position in GENI in Q1 2025 and held it in 2 quarters. The position peaked at $118K in Q1 2025. 275 funds tracked by Wall St. Rank hold GENI as of Q2 2026.

  • PharVision Advisers reported no remaining Genius Sports position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 17,672 Genius Sports shares in Q2 2026, an estimated $78.3K.
  • PharVision Advisers first reported a position in Genius Sports in Q1 2025 and held it in 2 quarters.
  • PharVision Advisers's Genius Sports position peaked at $118K in Q1 2025.
  • 275 funds tracked by Wall St. Rank held Genius Sports as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.